• FDA Clears Tezacaftor/Ivacaftor Combo for Cystic Fibrosis

    8 monthes ago - By Medscape

    Symdeko is for people aged 12 years and older who have two copies of the F508del mutation in the CFTR gene or who have at least one mutation that is responsive to tezacaftor/ivacaftor.
    FDA Approvals
    Read more ...